Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOath Surgical announced an oversubscribed $24 million Series A on October 6, 2025, led by FPV Ventures, with McKesson Ventures and existing investors participating. The company said the round brought its total reported funding to $35 million. Oath plans to use the capital to expand outpatient surgery centers, add specialties including oncology, and develop OathOS, software intended to coordinate surgical care from referral through recovery. The headline describes the company’s ambition; the announcement does not establish that Oath is the first such system or that its reported results have been independently validated.
What Oath announced
The $24 million Series A was led by FPV Ventures. McKesson Ventures joined alongside existing investors Oxford Science Enterprises, Black Opal Ventures, Tau Ventures, and Rogue VC. Oath reported that its total funding reached $35 million after the round; the announcement does not detail the composition or terms of all prior funding. The company was founded by Oliver Keown, MD.
Oath said it would direct the financing toward expanding its surgeon-owned, technology-enabled surgery-center network nationally, entering additional specialties such as oncology, and continuing development of OathOS. The round was announced on October 6, 2025, so it should not be read as confirmation of the company’s footprint or operating performance in 2026. (Oath’s funding announcement)
Oath is combining facilities, surgeons, and software
Oath is not pitching itself as only a software vendor. Its model connects three elements: outpatient surgery facilities, a network of surgeon partners, and OathOS, a software platform intended to coordinate care and facility operations. The company’s earlier launch announcement described OathOS as a full-stack operating system linked to its physical centers. (OathOS launch announcement)
#1 Best Overall
- Needle Holder Instrument
- Adson forceps
- Best rated in Professional medical supplies
- Surgical instrument kit
That combination could give Oath more control over how a surgical episode is organized than a standalone software company would have. It also makes the business more operationally demanding: running or aligning with facilities entails staffing, credentialing, equipment, quality systems, payer relationships, and safe escalation when a patient needs hospital-level care.
What “surgeon-owned” establishes—and what it does not
Oath describes its network as surgeon-owned or surgeon-aligned and says surgeons retain autonomy. The available announcements do not explain the legal ownership structure of each center, whether surgeons hold equity directly or through joint ventures, how Oath participates financially, or who controls governance and compensation. The label alone therefore does not establish that surgeons own every facility or that Oath has no corporate ownership interest.
Surgeon participation may align clinical expertise with facility operations, but it also raises practical questions about decision rights, referral incentives, and how common quality standards are enforced. Those details matter to surgeons assessing an affiliation, payers evaluating a network, and patients trying to understand who is accountable for their care.
What OathOS is intended to do
Oath says OathOS is designed to replace a patchwork of scheduling, billing, reporting, and workflow tools with a shared platform. Its stated scope runs from referral and scheduling through procedure coordination and recovery, linking patients, surgeons, facilities, and payers. The company describes automation, real-time data access, and an AI-enabled operating-room workflow layer as parts of that system.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Rank #2
- 18 Pieces in carrying case - Everything you need to practice techniques and dissecting skills. Premium grade stainless steel dissection kit is perfect for students, teachers, artists and other professionals looking to perform their work safely, and effectively.
That description is of a care-delivery and operations platform, not a disclosed robotic surgical system. The announcements do not describe OathOS as performing surgery autonomously. Nor do they specify which tasks are automated, which decisions require clinician approval, what systems it integrates with, or how errors and downtime are handled. Those distinctions are essential when judging what “AI-powered” means in practice.
Why outpatient surgery is the opportunity
Oath’s investment thesis rests on moving appropriate procedures from hospitals to outpatient settings. Outpatient facilities can have lower facility costs, while advances in minimally invasive techniques, anesthesia, patient selection, and postoperative monitoring have made more procedures feasible without an inpatient stay. Payers may also have reason to favor a lower-cost site when the setting is clinically appropriate.
The opportunity is not simply a software problem. Safe outpatient care depends on coordinating scheduling, staffing, credentialing, equipment, authorizations, follow-up, and a rapid transfer pathway if complications arise. A digital platform could help manage those handoffs, but it cannot substitute for clinical judgment, appropriate patient selection, or emergency readiness.
Oath’s funding announcement cited a projection that Medicare would allow more than 51 million procedures to move to outpatient settings by 2026. The release did not identify the underlying CMS document, methodology, or precise meaning of “allow,” so the figure is best treated as the company’s cited market projection, not a verified count of procedures that actually moved.
Rank #3
- 82 PCS PREMIUM GERMAN STAINLESS VETERINARY INSTRUMENTS SET -INCLUDE KELLY FORCEPS MOSQUITO FORCEPS CARMALT TOWEL CLAMP MAYO METENBAUM , MAYO SCISSORS-SPAY PACK SET ( CYNAMED BRAND ) ALL IN ONE
- SET INCLUDES: 1 PREMIUM GERMAN GRADE OLSEN HEGAR NEEDLE HOLDER 5.5" ( BLUE ) 1 PREMIUM GERMAN GRADE OLSEN HEGAR NEEDLE HOLDER 5.5" 1 PREMIUM GERMAN GRADE ALLIS TISSUE 4X5 TEETH 7" 4 PREMIUM GERMAN GRADE BACKHAUS TOWEL CLAMP 3.5" 1 PREMIUM GERMAN GRADE SCALPEL HANDLE #3 1 PREMIUM GERMAN GRADE MOSQUITO HEMOSTAT FORCEPS 5" STRAIGHT 2 PREMIUM GERMAN GRADE MOSQUITO HEMOSTAT FORCEPS 5" CURVED 2 PREMIUM GERMAN GRADE KELLY HEMOSTAT FORCEPS 5" STRAIGHT
- 2 PREMIUM GERMAN GRADE KELLY HEMOSTAT FORCEPS 5" CURVED 1 PREMIUM GERMAN GRADE SNOOK OVERIECTOMY HOOK 8" 1 PREMIUM GERMAN GRADE METZENBAUM SCISSORS 6.75" CURVED 1 PREMIUM GERMAN GRADE METZENBAUM SCISSORS 6.75" STRAIGHT 1 PREMIUM GERMAN GRADE MAYO DISSECTING SCISSORS 6.75" CURVED 1 PREMIUM GERMAN GRADE ADSON BROWN FORCEPS 4.75" 9X9TEETH
- 1 PREMIUM GERMAN ROCHESTER CARMALT ARTERY FORCEPS 6.25" CURVED 1 PREMIUM GERMAN ROCHESTER CARMALT ARTERY FORCEPS 6.25" STRAIGHT
- 20 SURGICAL STERILE BLADE #10 20 SURGICAL STERILE BLADE #11 20 SURGICAL STERILE BLADE #15
Specialties and expansion plans
The October 2025 announcement referenced urology, gynecology, general surgery, neurology and spine, ear, nose, and throat, orthopedics, pain, and other multispecialty programs, while identifying oncology as an area for expansion. It described national growth as a plan and cited a West Coast proof point; it does not establish that every listed specialty was available nationwide.
Oath’s May 2025 launch announcement said the company had acquired two centers and had a third de novo center in development at that time. Those are dated milestones, not a verified account of its current center count. (May 2025 launch announcement)
Why oncology is a demanding next step
Oncology may broaden the addressable work, but it can require more than an operating room and scheduling software. Care can depend on coordination with imaging, pathology, medication management, multidisciplinary teams, patient navigation, and hospital backup. Expanding into oncology will test whether Oath’s operating model can support more complex pathways while maintaining appropriate case selection and continuity of care.
Oath’s early metrics are company-reported
In its October 2025 announcement, Oath said that after roughly 12 months it had more than 150 surgeon partners and reported the following early results. These figures are company claims, not independently established outcomes in the cited announcement.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Rank #4
- PROFESSIONAL-GRADE PRECISION: Medical-grade dissection instruments are crafted from certified German stainless steel, precisely weighted and balanced for optimal control during extended procedures, maintaining surgical sharpness and resisting corrosion, purpose-built for college, medical, and veterinary dissection
- COMPREHENSIVE ANATOMY LAB SOLUTION: Complete 46-piece set includes 3 surgical scalpel handles with 20 sterile blades, precision scissors, specialized forceps, tissue clamps, and tissue probes for college, medical, and veterinary dissection studies
- GERMAN ENGINEERING EXCELLENCE: Precision-machined handles fit standard surgical blades for a secure, wobble-free fit during dissection and are compatible with multiple blade contours. The handles use the same certified German stainless steel found in professional surgical settings
- ORGANIZATION & PROTECTION: Premium microfiber lining and individual instrument slots with elastic retention prevent movement during transport and protect fine cutting edges, with specialized compartments for blades and small components
- LIFETIME PROFESSIONAL GUARANTEE: Every BioPrecision Advanced Kit is backed by our unconditional lifetime guarantee. If any instrument fails to perform to professional standards, we will replace it immediately
| Metric | What Oath reported | What is not established in the announcement |
|---|---|---|
| Surgeon network | More than 150 surgeon partners | How “partner” is defined, how many are active, or their geographic and specialty distribution |
| Cost | Up to 80% savings versus hospital-based procedures; savings as high as $100,000 in some cases | Average savings, procedure mix, comparison group, geography, and whether the calculation includes all professional, facility, anesthesia, implant, follow-up, and complication costs |
| Complications | Below 0.25% across what Oath called complex surgeries | Numerator, denominator, definition of complication, follow-up period, case mix, and risk adjustment |
| Patient satisfaction | About 98.5% | Survey method, response rate, timing, and whether nonrespondents or dissatisfied patients are represented |
| Recovery and discharge | Same-day discharge and recovery measured in days rather than weeks or months | Which procedures and patients these statements cover, and the comparison used for recovery time |
Oath CEO Oliver Keown separately cited a 98.3% average patient-satisfaction score in an investor-related social-media post, slightly different from the 98.5% in the formal announcement. (Black Opal Ventures post)
“Up to” describes a maximum, not a typical result, and same-day discharge does not mean every patient is eligible or that risk is absent. Without denominators and methods, the figures are useful as indicators of what Oath wants to demonstrate, but they are not enough to compare its outcomes with hospitals or other surgery centers. The funding announcement does not identify specific payer contracts, bundled-payment arrangements, or shared-savings agreements that would show how these results translate into contracted savings.
What McKesson Ventures’ investment may signal
McKesson Ventures’ participation gives Oath a strategic healthcare investor alongside its venture lead. McKesson describes its venture arm as investing in companies working on healthcare quality, access, and affordability. That involvement could bring relevant industry relationships or operating insight, but it does not by itself establish a commercial partnership, customer contract, supply agreement, or distribution arrangement. (McKesson Ventures’ account)
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.The main execution and safety questions
Patient selection and clinical escalation
Not every patient or procedure is appropriate for outpatient care. Comorbidities, anesthesia risk, procedure complexity, postoperative support, distance from emergency services, and the ability to transfer rapidly can all matter. A lower-cost setting only works if the clinical and operational safeguards fit the cases being treated.
Best Value
- ITEM: Cynamed-Gold Premium German 82 Pcs Veterinary Instruments Set -Include Kelly Forceps- Mosquito Forceps -Carmalt Forceps -Backhaus Towel Clamp- Mayo Metzenbaum Scissors- All in ONE -SURGICAL DENTAL INSTRUMENT SET
- SET INCLUDES: 1 O.R GERMAN GRADE OLSEN HEGAR NEEDLE HOLDER 5.5" ( GOLD ) 1 O.R GERMAN GOLD HANDLE CARMALT ARTERY FORCEPS 6.25" STRAIGHT 1 O.R GERMAN GOLD HANDLE CARMALT ARTERY FORCEPS 6.25" CURVED 1 O.R GERMAN GRADE ALLIS TISSUE 4X5 TEETH 7" ( GOLD ) 4 O.R GERMAN GRADE BACKHAUS TOWEL CLAMP 3.5" ( GOLD ) 1 O.R GERMAN GRADE SCALPEL HANDLE #3 ( GOLD ) 1 O.R GERMAN GRADE SCALPEL HANDLE #4 ( GOLD )
- 1 O.R GERMAN GRADE MOSQUITO HEMOSTAT FORCEPS 5" STRAIGHT ( GOLD ) 2 O.R GERMAN GRADE MOSQUITO HEMOSTAT FORCEPS 5" CURVED ( GOLD ) 2 O.R GERMAN GRADE KELLY HEMOSTAT FORCEPS 5" STRAIGHT ( GOLD ) 2 O.R GERMAN GRADE KELLY HEMOSTAT FORCEPS 5" CURVED ( GOLD ) 1 O.R GERMAN GRADE SNOOK OVERIECTOMY HOOK 8" ( GOLD ) 1 O.R GERMAN GRADE METZENBAUM SCISSORS 9" CURVED ( GOLD )
- 1 O.R GERMAN GRADE MAYO DISSECTING SCISSORS 6.75" STRAIGHT ( GOLD ) 1 O.R GERMAN GRADE MAYO DISSECTING SCISSORS 6.75" CURVED ( GOLD ) 1 O.R GERMAN GRADE ADSON BROWN FORCEPS 4.75" SERRATED ( GOLD ) 20 SURGICAL STERILE BLADE #10 20 SURGICAL STERILE BLADE #11 20 SURGICAL STERILE BLADE #22
Automation, accountability, and integration
Errors in scheduling, authorizations, documentation, triage, or postoperative follow-up can create clinical and financial consequences. A unified platform may reduce handoffs, but the company has not publicly detailed in the cited announcements how its AI is validated, where human approval is required, how decisions are audited, or what happens when the system is unavailable. Integration with electronic health records, imaging, anesthesia, revenue-cycle tools, and payer portals is another practical test; a platform that adds duplicate work rather than removing it would undermine its value.
Scaling quality across locations
National expansion means navigating state facility rules, licensing, credentialing, payer contracts, labor markets, supply chains, referral patterns, privacy obligations, and emergency-transfer arrangements that vary by location. Growth into new specialties can also change the case mix. If expansion outruns quality oversight—or if favorable outcomes reflect selection of lower-risk patients or incomplete follow-up—the early metrics may not generalize.
Economics and incentives
Oath’s model depends on sufficient patient volume and payer acceptance, not just lower facility costs in theory. Payers must be willing to steer appropriate cases to affiliated centers, and surgeon alignment must coexist with clinical independence and utilization safeguards. Combining software, facilities, and provider relationships may help coordinate the full episode, but it can also create conflicts that a neutral software vendor would not face.
What the financing does—and does not—show
The Series A gives Oath capital to develop OathOS and expand its outpatient network, with oncology among its stated areas of growth. The core proposition is a vertically integrated operating model for surgery, rather than an AI application operating independently of clinical facilities. The funding announcement documents the company’s plans and reported early metrics; it does not establish that the model’s savings and outcomes are independently validated, reproducible across specialties, or proven at national scale.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
